Last reviewed · How we verify
NCT05956990
Multidimensional Rehabilitation Intervention in Colorectal Cancer Survivors
NA trial testing multidimensional rehabilitation in Colorectal Cancer Survivor in 60 participants. Status unknown.
1 October 2025
Quick facts
| Lead sponsor | Qu Shen |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 1 July 2024 |
| Primary completion | 1 October 2025 |
| Estimated completion | 1 December 2025 |
Drugs / interventions tested
- multidimensional rehabilitation
Conditions studied
- Colorectal Cancer Survivor — all drugs for Colorectal Cancer Survivor →
- Rehabilitation — all drugs for Rehabilitation →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Qu Shen
Who can join
Adults 18 to 65, any sex, with Colorectal Cancer Survivor or Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A metaverse-based multidimensional rehabilitation program will be implemented for colorectal cancer survivors who have undergone curative surgery and adjuvant therapy. The intervention is based on the behavior change wheel and includes dietary intervention, exercise intervention, psychological support, and behavior management. Through various methods such as training, education, and motivation, the program aims to enhance the patients' functional ability, opportunities, and motivation, thereby promoting healthy behavior. Outcome measures include quality of life, fear of recurrence, and adoption of a healthy lifestyle. The intervention period is 4 weeks, with evaluations conducted at baseline and week 4 of the intervention
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Metaverse in Mental Health: The Beginning of a Long History.
Cerasa A, Gaggioli A, Pioggia G, Riva G. · · 2024 · cited 11× · PMID 38602624 · DOI 10.1007/s11920-024-01501-8 -
Effect of a metaverse multimodal rehabilitation intervention on quality of life and fear of recurrence in patients with colorectal cancer survivors: A randomized controlled study protocol.
Hu Y, Peng H, Su G, Chen B, et al · · 2024 · cited 2× · PMID 39564355 · DOI 10.1177/20552076241295542
Verify or expand the search:
- PubMed search for NCT05956990
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of multidimensional rehabilitation
Trials testing the same drug.
- NCT05957289 — Multidimensional Rehabilitation Intervention in Colorectal Cancer Survivors - a Pilot Study · NA · unknown
Other Qu Shen trials
Trials by the same sponsor.
- NCT07492290 — Empirical Study on Lifestyle Intervention for Elderly Hypertensive Patients in Community Based on TTM Theory · NA · not yet recruiting
- NCT07362823 — A Study on the Efficacy of the Metaverse Lifestyle Health Education Model Based on the Transtheoretical Model for Improv · NA · not yet recruiting
- NCT05957289 — Multidimensional Rehabilitation Intervention in Colorectal Cancer Survivors - a Pilot Study · NA · unknown
- NCT06354595 — Feasibility Study of Multidimensional Rehabilitation in the Metaverse · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05956990 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qu Shen
- Last refreshed: 20 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05956990.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing